FENC Reports $44.6M Net Product Sales, +50% YoY; $13.8M Q4 Sales, +75% YoY; $42M Oversubscribed Equity Offering; Positive Japan Study Topline; Conference Call 8:30 a.m. ET
Fennec Pharmaceuticals Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $9.88
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS